[ad_1]
London: Scientists have been developing an eye drop that can be self-administered, thus revolutionizing treatment for age-related macular degeneration (AMD) – the leading cause of blindness in the developed world.
Currently treated by injections of 2020, 000 scientists have been developing an alternative, but it is estimated that by 2020 there will be about 200 million people worldwide with AMD.
However, scientists at the Britain's University of Birmingham have been developing an alternative treatment in the form of an easy-to-use eye drop.
After earlier proving that the drop has a similar therapeutic effect as injections do in rodents, the team investigating the drug in rabbits and pigs, which have eyes that are
"For several ye, the new study demonstrates that the eye drops can be a therapeutically effective amount of the drugs to the retina of the larger mammalian eye. "said Felicity of Cogan, biochemist from the varsity."
"From the outset, we realized that delivering drugs through eye drops would mean that patients They could administer their treatment themselves, and it would be cheaper, save time for patients and healthcare providers, and reduce the potential complications that can arise from injections, "he added.
The technology, detailed in the journal Investigative Ophthalmology and Visual Science (IOVS), behind the eye drops is a cell-penetrating peptide that can deliver the drug to the retina.
"Cell-Penetrating Peptides Will Drive the Next Generation of Treatment for People with AMD , "noted Robert Scott, Professor at the varsity.
" They will be transformative for patients who currently have their intraocular injections
Clinical trials could start as early as 2019, the researchers said.
(IANS)
Source link
